European Journal of Case Reports in Internal Medicine · 2019 · 13 citations · 8 references
Life SciencesCardiologyPathologyMass Spectrometric AnalysisMolecular PathologyProteomicsAmyloid FormationCardiac Amyloidosis ImagingCardiac BiomarkersClinical ProteomicsMass Spectrometry-based ProteomicsPeptide AnalysisAmyloid PlaquesAmyloid Subtype DifferentiationApolipoprotein DisordersDifferential Diagnosis CriteriaMass Spectrometry ProteomicsMass Spectrometry-based Protein IdentificationProtein AggregatesProteomic Classification
Amyloidosis is a group of disorders characterised by the accumulation of extracellular deposits of insoluble protein aggregates. Clinical management depends on the accurate identification of the amyloid precursor and underlying cause. We describe a rare case of apolipoprotein A-IV cardiac amyloidosis, the diagnosis of which required mass spectrometry-based proteomic analysis. LEARNING POINTS: To be able to perform the differential diagnosis of cardiac amyloidosis subtypes using imaging methods, analytical results and tissue analysis.To recognise the added value of mass spectrometry (MS)-based proteomic analysis.
8
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text
Amyloidosis-where are we now and where are we heading?
Maria M. Picken · PubMed · 2010 · 146 citations
Medicine, Nephrology, Pathology +13